NASDAQ:TRNX - Taronis Technologies Stock Price, Forecast & News

Taronis Technologies trades on the NASDAQ under the ticker symbol "TRNX."

Taronis Technologies Inc (NASDAQ:TRNX) posted its quarterly earnings results on Wednesday, November, 20th. The company reported ($0.49) EPS for the quarter. The business had revenue of $5.32 million for the quarter. Taronis Technologies had a negative net margin of 129.20% and a negative return on equity of 78.94%. View Taronis Technologies' Earnings History.

Taronis Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Taronis Technologies.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Taronis Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Taronis Technologies.

Media coverage about TRNX stock has been trending extremely negative recently, according to InfoTrie. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Taronis Technologies earned a news sentiment score of -5.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Taronis Technologies.

Taronis Technologies saw a decrease in short interest during the month of January. As of January 31st, there was short interest totalling 2,070,000 shares, a decrease of 23.0% from the January 15th total of 2,690,000 shares. Based on an average trading volume of 2,230,000 shares, the days-to-cover ratio is presently 0.9 days. Currently, 8.6% of the company's stock are sold short. View Taronis Technologies' Current Options Chain.

Some companies that are related to Taronis Technologies include ASML (ASML), Lam Research (LRCX), Atlas Copco (ALFVY), ASM International (ASMIY), WARTSILA OYJ/ADR (WRTBY), GEA Group Aktiengesellschaft (GEAGY), IHI CORP/ADR (IHICY), Brooks Automation (BRKS), Bodycote (BYPLF), Milacron (MCRN), Axcelis Technologies (ACLS), Veeco Instruments (VECO), ACM Research (ACMR), Energy Recovery (ERII) and Intevac (IVAC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Taronis Technologies investors own include FuelCell Energy (FCEL), Actinium Pharmaceuticals (ATNM), Nabriva Therapeutics (NBRV), Canopy Growth (CGC), NIO (NIO), AcelRx Pharmaceuticals (ACRX), Inpixon (INPX), Titan Pharmaceuticals (TTNP), Aphria (APHA) and Biopharmx (BPMX).

Taronis Technologies' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Oxford Asset Management LLP (0.57%).

TRNX stock was acquired by a variety of institutional investors in the last quarter, including Oxford Asset Management LLP.

Shares of TRNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TRNX stock can currently be purchased for approximately $0.65.

Taronis Technologies has a market capitalization of $21.52 million and generates $9.71 million in revenue each year. View Additional Information About Taronis Technologies.

The official website for Taronis Technologies is http://www.magnegas.com/.

Taronis Technologies' mailing address is 300 W. CLARENDON AVENUE SUITE 230, PHOENIX AZ, 85013. The company can be reached via phone at 866-370-3835 or via email at [email protected]